Serodus ASA is pleased to invite shareholders, investors and other stakeholders to a presentation on both Monday 24. October 2016 at 16:00-17:00, and Tuesday 25. October 2016 at 09:00-10:00. The two sessions will cover the same subjects.

The program will cover the following:

* Status on development programs

* Proposal to delisting from Oslo Axess

* Plans going forward

The event will take place at Hotel Continental, Stortingsgaten 24/26, Oslo.

Corporate management will be available throughout the event and the presentations will be held in English. The Event will replace the presentation of Q3 report, which will be published on the 27th October 2016. A live webcast from the presentation can be accessed at www.serodus.com/Investor and at http://webtv.hegnar.no/presentation.php?webcastId=41005797 on Monday 24. October 2016, and at http://webtv.hegnar.no/presentation.php?webcastId=41005950 on Tuesday 25. October 2016. There will be possibilities for asking questions in English/Norwegian/Danish.

For more information, please consult www.serodus.com or contact:

Tore Kvam

CFO, Serodus ASA

Mobile: +47 959 34 199

e-mail: tore.kvam@serodus.com

Serodus ASA is a Norwegian drug development company, focusing on new therapeutic products for the treatment of diabetes and diabetic comorbidities with large unmet clinical needs. The company's business model is to seek partnering with international pharmaceutical companies after having demonstrated clinical effect in humans. For more information, see www.serodus.com.

Serodus ASA published this content on 17 October 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 22 October 2016 11:23:01 UTC.

Original documenthttp://www.serodus.com/News/2016/Invitation-for-shareholders-meeting

Public permalinkhttp://www.publicnow.com/view/410C2FFC5A8E2C1A55188CE79AAAD54290AA96EA